Cinctive Capital Management LP Procept Bio Robotics Corp Transaction History
Cinctive Capital Management LP
- $1.78 Billion
- Q2 2025
A detailed history of Cinctive Capital Management LP transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Cinctive Capital Management LP holds 43,583 shares of PRCT stock, worth $1.51 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
43,583Holding current value
$1.51 Million% of portfolio
0.14%Shares
1 transactions
Others Institutions Holding PRCT
# of Institutions
289Shares Held
44MCall Options Held
236KPut Options Held
91.9K-
Vanguard Group Inc Valley Forge, PA5.25MShares$182 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$121 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY2.16MShares$74.9 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.53MShares$53 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.32MShares$45.9 Million0.01% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $1.55B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...